Skip to content
Home/Companies/Biotech/Brainzell

Brainzell

Biotech·Sweden·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Brainzell?

Brainzell is a Swedish Biotech company, currently owned by Norrsken Accelerator since 2024.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Norrsken Accelerator
Investor
Norrsken Accelerator
Norrsken Accelerator · 2021 · VC

Key facts

HQSweden
SectorBiotech
StatusActive

More from Norrsken Accelerator

Other portfolio companies in the same fund.

Rinse
Rinse
Active
ConsumerUnited States
Everilabs
Active
HealthTechSweden· 2026
Spiral Hydrogen
Active
ClimateTechEstonia· 2026
Tolemy Bio
Active
BiotechSpain· 2026
Aiomics
Active
HealthTechGermany· 2025
Atmospheric AI
Active
ClimateTechUK· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Brainzell?

Brainzell is currently owned by Norrsken Accelerator, through Norrsken Accelerator, since 2024.

When did Norrsken Accelerator acquire Brainzell?

Norrsken Accelerator acquired Brainzell in 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue